CHICAGO—PSA levels at the time of initial screening among men aged 44-50 years can accurately predict the risk that a man will die from prostate cancer (PCa) or develop metastatic PCa up to 30 years ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results